CRISPR Therapeutics to Present at Needham Healthcare Conference
Event summary
- CRISPR Therapeutics will present at the 25th Annual Needham Virtual Healthcare Conference on April 13, 2026, at 2:15 p.m. ET.
- A live webcast of the fireside chat will be available on the company's website, with a replay archived for 14 days.
- CRISPR Therapeutics is a leading biopharmaceutical company focused on gene-based medicines, with the approval of CASGEVY®, the world’s first CRISPR-based therapy.
- The company is advancing a diversified pipeline across multiple therapeutic areas and has strategic collaborations, including with Vertex Pharmaceuticals.
The big picture
CRISPR Therapeutics' presentation at the Needham Healthcare Conference comes at a time when the biopharmaceutical industry is increasingly focused on gene editing technologies. The company's approval of CASGEVY® marks a significant milestone, positioning it as a leader in the field. Strategic collaborations and pipeline advancements will be crucial in maintaining this leadership and driving future growth.
What we're watching
- Pipeline Progress
- The pace at which CRISPR Therapeutics advances its diversified pipeline across multiple therapeutic areas will be critical to watch.
- Strategic Collaborations
- Whether CRISPR Therapeutics can sustain and expand its strategic collaborations, particularly with Vertex Pharmaceuticals, will be a key factor.
- Market Impact
- How the presentation at the Needham Healthcare Conference will affect investor sentiment and market positioning.
Related topics